PRACHI BAJPAI
University of Alabama at Birmingham
H-index: 15
North America-United States
Top articles of PRACHI BAJPAI
Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma
Neoplasia
2024/1/1
Regorafenib antitumor immune response is enhanced by a novel drug combination in CRC syngeneic model
Cancer Research
2024/3/22
Targeting prolyl 4-hydroxylase subunit alpha 1 with a small molecule inhibitor, diethyl-pythiDC, reduces pancreatic ductal adenocarcinoma growth and metastasis
Cancer Research
2024/3/22
Abstract A006: Differential gene expression to delineate racial disparities in the molecular landscape of pancreatic ductal adenocarcinoma
Cancer Research
2024/1/16
BZW2 inhibition reduces colorectal cancer growth and metastasis
Molecular Cancer Research
2023/7/5
Microbiome diversity in African American, European American, and Egyptian colorectal cancer patients
Heliyon
2023/7/1
The prognostic significance of prolyl 4-hydroxylase subunit alpha 1 and the therapeutic efficacy of diethyl-pythiDC, its small molecule inhibitor, in pancreatic ductal …
Cancer Research
2023/4/4
Molecular subtyping and survival analysis of osteosarcoma reveals prognostic biomarkers and key canonical pathways
Cancers
2023/4/4
BZW2 a potential target to inhibit colorectal cancer growth and metastasis
Cancer Research
2023/4/4
Pharmacologic targeting or silencing of TRIP13 reduces progression of pancreatic ductal adenocarcinoma
Cancer Research
2023/4/4
Developing 3D Organoid Raft Cultures from Patient-Derived Xenografts as Rapid Models to Screen Efficacy of Experimental Therapeutics
International journal of molecular sciences
2022/11/19
A high‐resolution 3D atlas of the spectrum of tuberculous and COVID‐19 lung lesions
EMBO molecular medicine
2022/11/8
A signature of Prevotella copri and Faecalibacterium prausnitzii depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patients
Journal of Gastrointestinal Oncology
2022/10
Reducing regorafenib toxicity by combining with dual JAK-HDAC inhibitor in colorectal cancer.
2022/6/1
DCZ0415, a small‐molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4/STAT3 axis and the Wnt/β‐catenin pathway in colorectal cancer
Molecular oncology
2022/4
Age-dependent heterogeneity of lymph node metastases and survival identified by analysis of a national breast cancer registry
Journal of pharmacy and pharmacology research
2022
Corrigendum to ‘Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model’[Translational Oncology 13 (2020) 100754]
Translational Oncology
2021/11
Positive Retrospective SARS-CoV-2 Testing in a Case of Acute Respiratory Distress Syndrome of Unknown Etiology.
Case Reports in Pulmonology
2021/8/28
Acute liver failure in a healthy young female with COVID-19
JPGN reports
2021/8/1
Immunophenotype‐associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent
Cancer Medicine
2021/8
